The mechanisms via which enzymes, such as IDO1, TDO2, and Kyn, promote CRC progression are well characterized, with the most critical pathway involving the activation of the IDO/TDO2‐Kyn‐AhR axis. The gene discussed is TDO2; the disease is colorectal carcinoma.